SIGN UP
LOG IN
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·07/10/2025 17:05:47
Listen to the news
Gainers
- Q32 Bio (NASDAQ:QTTB) shares moved upwards by 52.3% to $2.3 during Thursday's regular session. The company's market cap stands at $18.4 million.
- Pelthos Therapeutics (AMEX:PTHS) shares moved upwards by 52.09% to $25.05. The company's market cap stands at $10.6 million.
- Cognition Therapeutics (NASDAQ:CGTX) stock increased by 39.28% to $0.74. The market value of their outstanding shares is at $32.9 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares rose 28.9% to $0.9. The company's market cap stands at $22.2 million.
- Lixte Biotechnology (NASDAQ:LIXT) shares increased by 28.54% to $3.54. The company's market cap stands at $7.5 million.
- ProKidney (NASDAQ:PROK) shares moved upwards by 23.96% to $5.38. The company's market cap stands at $562.1 million.
Losers
- Mereo BioPharma Group (NASDAQ:MREO) shares decreased by 38.8% to $1.8 during Thursday's regular session. The market value of their outstanding shares is at $467.4 million.
- Ultragenyx Pharmaceutical (NASDAQ:RARE) stock fell 27.42% to $30.08. The company's market cap stands at $3.9 billion.
- Creative Medical Tech (NASDAQ:CELZ) stock decreased by 22.21% to $3.06. The company's market cap stands at $10.1 million.
- NeOnc Technologies (NASDAQ:NTHI) shares decreased by 21.25% to $4.69. The market value of their outstanding shares is at $113.3 million.
- Citius Oncology (NASDAQ:CTOR) stock fell 19.13% to $3.51. The company's market cap stands at $310.5 million.
- Basel Medical Group (NASDAQ:BMGL) shares decreased by 16.8% to $3.01. The market value of their outstanding shares is at $68.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.